Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling
Dimitrios G. Patsatzis

TL;DR
This paper applies algorithmic asymptotic analysis to a complex cancer immunology model, simplifying it to reveal key mechanisms and improve predictive accuracy during tumor progression, aiding treatment development.
Contribution
It introduces an algorithmic approach using Computational Singular Perturbation to derive a reduced, mechanistic model from a complex tumor-immune interaction system.
Findings
The long-term tumor dynamics depend on an initial explosive growth stage.
The reduced model accurately predicts explosive stage dynamics with fewer parameters.
Insights are consistent across different tumor-immune and patient scenarios.
Abstract
The recent advances in cancer immunotherapy boosted the development of tumor-immune system models aiming to provide mechanistic understanding and indicate more efficient treatment regimes. However, the complexity of such models, their multi-scale dynamics and their overparameterized character renders them inaccessible for wide utilization. In this work, the dynamics of a fundamental model formulating the interactions of tumor cells with natural killer cells, CD8 T cells and circulating lymphocytes is examined. It is first shown that the long-term evolution of the system towards high-tumor or tumor-free equilibria is determined by the dynamics of an initial \emph{explosive stage} of tumor progression. Focusing on this stage, the algorithmic Computational Singular Perturbation methodology is employed to identify the underlying mechanisms confining the system's evolution towards the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMathematical Biology Tumor Growth · Cancer Immunotherapy and Biomarkers · Monoclonal and Polyclonal Antibodies Research
